Table 1 Primary malignancies

From: Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies

 

Without therapy-related myeloid neoplasm

With therapy-related myeloid neoplasm

Chronic lymphocytic leukemia

26

4

Plasma cell myeloma

14

1

Follicular lymphoma

7

4

Diffuse large B-cell lymphoma

8

3

Mantle cell lymphoma

3

2

Classical Hodgkin lymphoma

2

0

B-lymphoblastic leukemia

1

0

Marginal zone lymphoma

1

0

Hairy cell leukemia

1

1

Enteropathy-associated T-cell lymphoma

1

0

Burkitt lymphoma

1

0

Lymphoplasmacytic lymphoma

1

0

Peripheral T-cell lymphoma

0

1

Breast cancer

1

1

Prostate cancer

0

2

Squamous cell carcinoma

0

1

Colon cancer

0

1

Compositea

4

0

  1. aComposite: one with breast cancer, diffuse large B-cell lymphoma, and angioimmunoblastic T-cell lymphoma; one with breast cancer, plasma cell myeloma, and lymphoplasmacytic lymphoma; one with follicular lymphoma and diffuse large B-cell lymphoma; and one with prostate cancer and mantle cell lymphoma.